Wearable Devices to Track Health in Blood Cancer Patients
Part of Blood & lymphatic, Cancer clinical trials.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with myelodysplastic syndrome (MDS), myeloproliferative/myelodysplastic overlap syndrome, myeloma, or acute myeloid leukemia (AML)
- You are planning to start or currently receiving treatment aimed at controlling your blood cancer
- You are expected to live at least 6 months
- You are able and willing to wear a device on your skin and complete occasional questionnaires about your health and quality of life
- You are willing to receive blood transfusions as part of your normal care with the NHS
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartphone app and a wearable watch to track your symptoms and daily activity. The information may help doctors better understand and manage MPN, and could lead to improved care.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This trial tests if using a connected scale to monitor your weight at home can help your doctors manage your treatment for aggressive non-Hodgkin's lymphoma or multiple myeloma. It may also apply if you need a stem cell transplant (autograft) for these conditions.
This study uses wearable heart monitors to check for heart problems during cancer treatment. Participants wear a small patch that tracks their heart rhythm, helping doctors detect issues early.
This trial tests a smartwatch tool to track heart rhythm and detect problems in people with heart disease. It may help find irregular heartbeats early during routine checkups.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
Hear when a new MDS (Myelodysplastic Syndrome) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.